BONESUPPORT APPOINTS ANDREAS MUCHOWSKI TO VP OF SALES GERMANY Muchowski will Lead Sales Recruiting and Prepare for Upcoming Product Launch


Lund, SWEDEN, BONESUPPORT, an emerging leader in injectable bone substitutes for orthopedic trauma, bone infections and instrument augmentation related to orthopedic replacement surgeries, today announced the appointment of Andreas Muchowski to the position of Vice President of Sales Germany. Andreas will lead sales recruiting efforts and prepare for the upcoming market launch of exciting new bone remodeling products for the prevention of deep bone infections related to disease and trauma

Andreas brings more than 20 years of successful sales and management experience within the medical device industry. Prior to joining BONESUPPORT, Andreas was Regional Manager of North and Eastern Regions for Stryker, and before that, he held several key positions at KCI.
Andreas Muchowski brings a wealth of career achievements in the device industry,” said Lloyd Diamond, CEO of BONESUPPORT. “He is a proven leader at driving revenue growth and we are confident that he will successfully guide our German sales team through the next phases of expansion.”

Drawing upon his vast experiences, Andreas is well positioned for his role at BONESUPPORT. “I look forward to building our direct sales organization and driving dynamic growth for the company,” said Mr. Muchowski. “CERAMENT is an exciting product that will have a significant impact on patients suffering from fragility fractures and bone infections. I’m proud to be a part of this effort to improve patient outcomes.”

For more information about BONESUPPORT and CERAMENT, visit their new site at www.BONESUPPORT.com.


BONESUPPORT is an emerging leader of injectable bone substitutes for orthopedic trauma focusing on bone infection, instrument augmentation related to orthopedic surgery and spinal applications. CERAMENTT is a fully developed product platform that is commercially available in the U.S. and Europe and is revolutionizing the treatment of fragility and other fractures caused by disease and trauma. Scientific research of CERAMENT spans more than eleven years and over forty-five pre-clinical, clinical and animal studies have been conducted. More than 4,000 patients have been treated with CERAMENT. The company was founded in 1999 and is based in Lund, Sweden with subsidiary locations in the US and Germany.

To learn more about BONESUPPORT please visit www.bonesupport.com.

Press Inquiries:
Fredrik Groth
Phone: +46 46 286 53 60


Hjernestimulation skal lindre symptomer ved Parkinsons sygdom
25. januar 2021
Minihjerner skal kaste lys over nervesygdomme
25. januar 2021
Mekanismer bag skizofreni
25. januar 2021


Lundbeckfonden Ventures

Lundbeckfonden Emerge